9月15日，Tempus AI盘中上涨5.14%，报65.36美元/股，成交额3800.94万美元。
消息面上，公司近期利好密集释放。9月11日，Tempus AI宣布将打造全球最大规模的多模态全基因组数据集，首批包含10万条全基因组序列及纵向临床数据，长期目标扩展至100万条，预计中期向公众开放。此外，9月10日公司获得美国高级卫生研究计划局（ARPA-H）最高950万美元资助，用于在心脏病学领域部署首款完全自主运行的AI临床代理系统，将开展多中心前瞻性研究。多项战略举措叠加此前FDA批准其AI肺动脉高压检测产品，持续巩固公司在AI医疗赛道的技术领先地位。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.